Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |